Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ICAD - FR0000035081 - REIT

21.22 EUR
+0.04 (+0.19%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

Overall ICAD gets a fundamental rating of 3 out of 10. We evaluated ICAD against 42 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
In the past year ICAD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.85%, ICAD is doing worse than 78.57% of the companies in the same industry.
ICAD has a worse Return On Equity (-4.79%) than 78.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.76%, ICAD is doing worse than 71.43% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICAD is in line with the industry average of 3.52%.
The last Return On Invested Capital (2.76%) for ICAD is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

With a Operating Margin value of 19.60%, ICAD is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
ICAD's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

ICAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ICAD has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ICAD has been increased compared to 5 years ago.
ICAD has a worse debt/assets ratio than last year.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.64, ICAD is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
ICAD has a debt to FCF ratio of 45.49. This is a negative value and a sign of low solvency as ICAD would need 45.49 years to pay back of all of its debts.
ICAD's Debt to FCF ratio of 45.49 is on the low side compared to the rest of the industry. ICAD is outperformed by 76.19% of its industry peers.
ICAD has a Debt/Equity ratio of 0.97. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
ICAD has a worse Debt to Equity ratio (0.97) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Altman-Z 0.64
ROIC/WACC0.97
WACC2.85%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.06 indicates that ICAD should not have too much problems paying its short term obligations.
The Current ratio of ICAD (1.06) is better than 80.95% of its industry peers.
A Quick Ratio of 0.81 indicates that ICAD may have some problems paying its short term obligations.
ICAD has a Quick ratio of 0.81. This is in the better half of the industry: ICAD outperforms 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
Measured over the past years, ICAD shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.69% on average per year.
ICAD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.82%.
Measured over the past years, ICAD shows a small growth in Revenue. The Revenue has been growing by 0.64% on average per year.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

ICAD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.99% yearly.
Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -1.58% on average per year.
EPS Next Y11.01%
EPS Next 2Y2.39%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue Next Year-6.66%
Revenue Next 2Y-2%
Revenue Next 3Y-1.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.12 indicates a rather cheap valuation of ICAD.
92.86% of the companies in the same industry are more expensive than ICAD, based on the Price/Earnings ratio.
ICAD is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 6.40, which indicates a rather cheap valuation of ICAD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 95.24% of the companies listed in the same industry.
ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
Industry RankSector Rank
PE 7.12
Fwd PE 6.4
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICAD is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
ICAD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.74
EV/EBITDA 10.52
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y2.39%
EPS Next 3Y-1.99%

4

5. Dividend

5.1 Amount

ICAD has a Yearly Dividend Yield of 5.48%, which is a nice return.
ICAD's Dividend Yield is comparable with the industry average which is at 5.84.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 5.48%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-185.46%
EPS Next 2Y2.39%
EPS Next 3Y-1.99%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (11/28/2025, 7:00:00 PM)

21.22

+0.04 (+0.19%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16/amc
Inst Owners73.36%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.62B
Revenue(TTM)1.50B
Net Income(TTM)-187.10M
Analysts69.47
Price Target24.91 (17.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.48%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-185.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.25%
PT rev (3m)-0.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.36%
EPS NY rev (3m)0.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 7.12
Fwd PE 6.4
P/S 1.08
P/FCF 15.74
P/OCF 4.93
P/B 0.41
P/tB 0.42
EV/EBITDA 10.52
EPS(TTM)2.98
EY14.04%
EPS(NY)3.31
Fwd EY15.61%
FCF(TTM)1.35
FCFY6.36%
OCF(TTM)4.31
OCFY20.3%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.65
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.86%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Debt/EBITDA 9.41
Cap/Depr 211.04%
Cap/Sales 15.05%
Interest Coverage 4.1
Cash Conversion 81.96%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.85%
ROIC/WACC0.97
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y11.01%
EPS Next 2Y2.39%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.66%
Revenue Next 2Y-2%
Revenue Next 3Y-1.58%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year51.07%
EBIT Next 3Y14.51%
EBIT Next 5Y8.67%
FCF growth 1Y240.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.57%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status for ICAD stock?

ChartMill assigns a valuation rating of 7 / 10 to ICADE (ICAD.PA). This can be considered as Undervalued.


Can you provide the profitability details for ICADE?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ICADE (ICAD.PA) stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.12 and the Price/Book (PB) ratio is 0.41.


Can you provide the dividend sustainability for ICAD stock?

The dividend rating of ICADE (ICAD.PA) is 4 / 10 and the dividend payout ratio is -185.46%.